Carlota Arias‐Hidalgo
Carlota Arias‐Hidalgo publishes mostly in Molecular Biology, Immunology and Spectroscopy, on topics such as Advanced Biosensing Techniques and Applications, Advanced Proteomics Techniques and Applications and Chronic Lymphocytic Leukemia Research.
- World rank
- #6,511,694 of 7,710,434 ranked researchers
- Rank in Spain
- #160,412 of 204,306
- Works
- 15
- Citations
- 99
- Citations per work
- 6.6
What does Carlota Arias‐Hidalgo research?
Carlota Arias‐Hidalgo's work is mostly in Biochemistry, Genetics and Molecular Biology (27%), Medicine (20%), Immunology and Microbiology (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences637.8%
- Everything else531.0%
- Health Sciences320.1%
- Medicine320.1%
- Physical Sciences211.1%
- Chemistry211.1%
- 1Molecular Biology27% of their works
- 2Immunology11% of their works
- 3Spectroscopy11% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Infectious Diseases7% of their works
- 6Epidemiology7% of their works
Research topics
- Advanced Biosensing Techniques and Applications
- Advanced Proteomics Techniques and Applications
- Chronic Lymphocytic Leukemia Research
- Monoclonal and Polyclonal Antibodies Research
- vaccines and immunoinformatics approaches
- Phagocytosis and Immune Regulation
- SARS-CoV-2 and COVID-19 Research
- Lymphoma Diagnosis and Treatment
Which keywords describe Carlota Arias‐Hidalgo's research?
The keywords of their largest research topics: Rituximab, High-Throughput Analysis, Mass Spectrometry, Protein Microarrays, Proteomics, Chronic Lymphocytic Leukemia, Fc Receptors and Genomic Aberrations.
- SARS-CoV-2
- Lymphoma
- Coronavirus
- CD47
- Genomic Aberrations
- Chronic Lymphocytic Leukemia
- Protein Microarrays
- High-Throughput Analysis
- Rituximab
- Mass Spectrometry
- Proteomics
- Fc Receptors
- Therapeutic Antibodies
- Classification
- Epitope Prediction
- Peptide-MHC Binding
- apoptotic cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Rituximab52 topics
- High-Throughput Analysis41 topic
- Mass Spectrometry41 topic
- Protein Microarrays41 topic
- Proteomics41 topic
- Chronic Lymphocytic Leukemia31 topic
- Fc Receptors31 topic
- Genomic Aberrations31 topic
- Therapeutic Antibodies31 topic
- CD4721 topic
- Classification21 topic
- Coronavirus21 topic
- Epitope Prediction21 topic
- Lymphoma21 topic
- Peptide-MHC Binding21 topic
- SARS-CoV-221 topic
- apoptotic cells21 topic
Where does Carlota Arias‐Hidalgo work?
Carlota Arias‐Hidalgo's main affiliation in the publication record is Instituto de Investigación Biomédica de Salamanca, Spain.
How many publications and citations does Carlota Arias‐Hidalgo have?
OpenAlex counts 15 works and 99 citations for Carlota Arias‐Hidalgo, an h-index of 6, ranking #6,511,694 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Carlota Arias‐Hidalgo. Posts are plain text and can be reported.